Committed to sustainable growth and long-term planning Dedicated to making investments to support increased customer demand Maintain efficiency a...
Phase 1 study for SB16, proposed biosimilar to Prolia, demonstrates pharmacokinetic (PK) bioequivalence between SB16, EU-sourced denosumab, and US-source...
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced the completion of the facilit...
Charles River Laboratories International, Inc. announced the launch of its lentiviral vector (LVV) manufacturing platform, Lentivation™. The pl...
New sites at Darmstadt and Hamburg complement Merck’s global integrated mRNA service network with pre-clinical to commercial capabilities Company&...
"Swiss CDMO Lonza Announces CEO Departure by Mutual Agreement; Chairman Baehny Takes the Helm Again Temporarily" Lonza, the Swiss Contract Development and...
Syneos Health is evolving its patient recruitment capabilities to further address unmet sponsor, site and patient needs. Through its collaboration with the...
HumanFirst, a cloud-based software company accelerating patient-centered drug development through AI-powered insights, today announced the launch of the in...
Enzene Biosciences, a subsidiary of Mumbai-India, based Alkem Laboratories, has announced the inauguration of its cutting-edge research and...
ISA Pharmaceuticals B.V., a clinical-stage biotech company developing immunotherapies to treat cancers and serious infectious diseases, is pleased to ...
SpendEdge, a global leader in procurement market intelligence space recently connected with a large Europe-based pharma company focused on large and small ...
Adding Four New Independent Directors Appoints John Greisch as Executive Chair Establishes New Strategic and Operational Review Committee of the Board ...
"We are thrilled to receive this investment from KITVEN and Conscience Multi Family Office," said Dr. Chandrashekaran. "This funding will empower us to f...
These models are essential for testing in vivo efficacy of novel therapeutics against lung cancer, elevating the prospects for significant advances in the ...
© 2025 Biopharma Boardroom. All Rights Reserved.
